Immatics US
-
2000
Company Description
Immatics US, Inc. was launched in June 2015 by Immatics GmbH and the University of Texas MD Anderson Cancer Center
Immatics US, Inc. was launched in June 2015 by Immatics GmbH and the University of Texas MD Anderson Cancer Center. The Company is developing Adoptive Cell Therapies (ACT) approaches based on Immatics’ unrivalled cancer target discovery capabilities and MD Anderson’s world-leading clinical oncology and cell therapy expertise.
-
Manufacturer:
Data and Analytics -
Formed:
2000 -
Company Website:
-
Company E-mail:
-
Company Address:
7000 Fannin Suite 2115, 2120 HoustonTexas City, TXUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits